Literature DB >> 2189162

Buerger's disease (thromboangiitis obliterans).

J W Joyce1.   

Abstract

Thromboangiitis obliterans is a progressive, often relentless and devastating, vasculitis causing significant loss of digits and limbs in a youthful population of tobacco users. Whereas the specific pathogenetic mechanism has not been defined, tobacco use is clearly a trigger for what appears to be an autoimmune mechanism in a given group of patients. Its cessation almost always prevents further tissue damage. Medical and surgical therapy palliate accrued damage, but only complete abstinence from tobacco use allows stabilization of the process. An appreciation of the characteristic clinical, angiographic, and histopathologic features allows specific diagnosis and differentiation from premature atherosclerosis and other mechanisms of distal and microcirculatory deficits. There is a pressing need for the evaluation of agents that might interrupt this process in the face of continued tobacco use; such an agent would be helpful in combating proliferative arterial change in other types of vasculitis.

Entities:  

Mesh:

Year:  1990        PMID: 2189162

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  8 in total

1.  Distribution of arterial involvement in thromboangiitis obliterans (Buerger's disease): results of a study conducted by the Intractable Vasculitis Syndromes Research Group in Japan.

Authors:  S Sasaki; M Sakuma; T Kunihara; K Yasuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 2.  Is Achenbach's syndrome a surgical emergency? A systematic review.

Authors:  A Kordzadeh; P L Caine; A Jonas; K M Rhodes; Y P Panayiotopolous
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-15       Impact factor: 3.693

3.  HLA antigens in Burger's disease.

Authors:  J Zervas; G Vayopoulos; K Konstantopoulos; C Zervas; C Liapis; P Kaklamanis; M Sechas
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

4.  Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report.

Authors:  Joaquin De Haro; Aurora Florez; Jose Luis Fernandez; Francisco Acin
Journal:  BMJ Case Rep       Date:  2009-05-12

5.  Buerger's Disease; Any Current Advances?

Authors:  Yong-Bok Koh
Journal:  Ann Vasc Dis       Date:  2008-10-24

6.  Two otherwise healthy young brothers present with intermittent claudication, just a coincidence?

Authors:  Thomas Clifford; Jonathan Moore
Journal:  BMJ Case Rep       Date:  2017-07-06

7.  The Wound Healing Effects of Iloprost in Patients with Buerger's Disease: Claudication and Prevention of Major Amputations.

Authors:  A Afsharfard; M Mozaffar; F Malekpour; A Beigiboroojeni; M Rezaee
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

Review 8.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Perttu E T Arkkila
Journal:  Orphanet J Rare Dis       Date:  2006-04-27       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.